Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brill

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Antibiotics|June 1, 1996
Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screenG M Brill, W M Kati, D Montgomery, et al.
Annals of Surgical Oncology|September 30, 2006
Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasisJoseph T Davis, Yolanda M Brill, Sam Simmons, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man studyHerbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2015
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation studyJohn F DiPersio, Harry P Erba, Richard A Larson, et al.
Neurobiology of Disease|April 1, 2019
NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent modelShu-Ichi Okamoto, Olga Prikhodko, Juan Pina-Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometryArthur R Salomon, Scott B Ficarro, Laurence M Brill, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Molecular and Cellular Biology|April 24, 2013
Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complexValentina Gandin, Gustavo J Gutierrez, Laurence M Brill, et al.
Circulation Research|June 3, 2015
Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signalsSu-Li Cheng, Bindu Ramachandran, Abraham Behrmann, et al.
Cell Metabolism|September 13, 2011
C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membraneXiangyang Xie, Zhenwei Gong, Virginie Mansuy-Aubert, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Antibiotics|June 1, 1996
Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screenG M Brill, W M Kati, D Montgomery, et al.
Annals of Surgical Oncology|September 30, 2006
Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasisJoseph T Davis, Yolanda M Brill, Sam Simmons, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man studyHerbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2015
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation studyJohn F DiPersio, Harry P Erba, Richard A Larson, et al.
Neurobiology of Disease|April 1, 2019
NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent modelShu-Ichi Okamoto, Olga Prikhodko, Juan Pina-Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometryArthur R Salomon, Scott B Ficarro, Laurence M Brill, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Molecular and Cellular Biology|April 24, 2013
Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complexValentina Gandin, Gustavo J Gutierrez, Laurence M Brill, et al.
Circulation Research|June 3, 2015
Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signalsSu-Li Cheng, Bindu Ramachandran, Abraham Behrmann, et al.
Cell Metabolism|September 13, 2011
C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membraneXiangyang Xie, Zhenwei Gong, Virginie Mansuy-Aubert, et al.
Pageof 9